Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Stephanie A. Angarita"'
Autor:
Linda Ye, Dennis Rünger, Stephanie A. Angarita, Joseph Hadaya, Jennifer L. Baker, Minna K. Lee, Carlie K. Thompson, Deanna J. Attai, Maggie L. DiNome
Publikováno v:
Breast Cancer Research and Treatment. 193:429-436
Autor:
Patrick C Lee, Brian Truong, Agustin Vega-Crespo, W Blake Gilmore, Kip Hermann, Stephanie AK Angarita, Jonathan K Tang, Katherine M Chang, Austin E Wininger, Alex K Lam, Benjamen E Schoenberg, Stephen D Cederbaum, April D Pyle, James A Byrne, Gerald S Lipshutz
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
Urea cycle disorders are incurable enzymopathies that affect nitrogen metabolism and typically lead to hyperammonemia. Arginase deficiency results from a mutation in Arg1, the enzyme regulating the final step of ureagenesis and typically results in d
Externí odkaz:
https://doaj.org/article/1fdc6566631f4520874fb9e231323021
Autor:
Deanna J. Attai, Nicole A. Dawson, Stephanie A.K. Angarita, Carlie K Thompson, Minna K Lee, Maggie L. DiNome, Dennis Rünger, Jennifer L. Baker, Linda Ye, Joseph Hadaya
Publikováno v:
Annals of Surgical Oncology. 28:2609-2618
Omission of axillary lymph node dissection (ALND) is accepted for patients with one or two positive sentinel nodes, and studies are focusing on clinically node-positive patients who have been downstaged with neoadjuvant chemotherapy (NAC). Evidence i
Autor:
Linda Ye, Carlie K Thompson, Deanna J. Attai, Dennis Rünger, Stephanie A.K. Angarita, Minna K Lee, Jennifer L. Baker, Maggie L. DiNome, Joseph Hadaya
Purpose: Omission of axillary lymph node dissection (ALND) is considered for patients with sentinel lymph node-positive (SLN+) breast cancer, but ALND remains the standard of care for clinically node-positive (cN+) patients treated with surgery first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d7aba83fd4a5ed0f81f34eca001332
https://doi.org/10.21203/rs.3.rs-1032846/v1
https://doi.org/10.21203/rs.3.rs-1032846/v1
Autor:
Irmina A. Elliott, Sergio Duarte, Piotr Ruchala, Tara A. Russell, Ali Zarrinpar, Julian P. Whitelegge, Stephanie A.K. Angarita
Publikováno v:
Journal of Surgical Research. 233:20-25
Background Loss of intestinal barrier integrity plays a fundamental role in the pathogenesis of various gastrointestinal diseases and is implicated in the onset of sepsis and multiple organ failure. An array of methods to assess different aspects of
Autor:
Alex K. Lam, Michael G. Lin, Stephanie A.K. Angarita, Suhail Khoja, Brian Truong, Abha K. Rajbhandari, Sergio Duarte, Matthew Nitzahn, Stephen D Cederbaum, Gerald S. Lipshutz, Irina Zhuravka
Publikováno v:
Molecular genetics and metabolism, vol 124, iss 2
The transplantation, engraftment, and expansion of primary hepatocytes have the potential to be an effective therapy for metabolic disorders of the liver including those of nitrogen metabolism. To date, such methods for the treatment of urea cycle di
Autor:
Danielle S. Graham, Stephanie A.K. Angarita, Jonathan Sack, Aaron J. Dawes, Tara A. Russell, Christina Ha
Publikováno v:
Diseases of the Colon & Rectum. 61:214-220
Background Severe acute refractory colitis has traditionally been an indication for emergent colectomy in IBD, yet under these circumstances patients are at elevated risk for complications because of their heightened inflammatory state, nutritional d
Autor:
Stephanie A.K. Angarita, Ronald W. Busuttil, Tara A. Russell, Fady M. Kaldas, Amy Showen, Vatche G. Agopian
Publikováno v:
The American Surgeon. 83:1152-1156
Elevated liver function tests (eLFTs) are a major cause of unplanned readmissions (UR) after orthotopic liver transplantation. Diagnostic workup for eLFTs requires multiple invasive and noninvasive procedures, often done in the inpatient setting to e
Autor:
Peter M. Clark, Sergio Duarte, Gerald S. Lipshutz, Owen N. Witte, Alicia Wong, Stephanie A.K. Angarita, Bao Ying Chen, Jessica R. Salas
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 59, iss 8
Drug-induced liver failure is a significant indication for a liver transplant, and unexpected liver toxicity is a major reason that otherwise effective therapies are removed from the market. Various methods exist for monitoring liver injury but are o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720d3364afb6d81351669d4c01cc40b9
https://escholarship.org/uc/item/2255h21p
https://escholarship.org/uc/item/2255h21p
Publikováno v:
Current opinion in organ transplantation. 22(4)
Pneumonia occurs in 8-23% of patients after liver transplantation and contributes considerably to their morbidity and mortality. With the increasing acuity of liver transplantation patients in the current era, pneumonias, particularly ventilator-asso